|
1
|
Ikai I, Arii S, Okazaki M, Okita K, Omata
M, Kojiro M, Takayasu K, Nakanuma Y, Makuuchi M, Matsuyama Y, et
al: Report of the 17th Nationwide Follow-up Survey of Primary Liver
Cancer in Japan. Hepatol Res. 37:676–691. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hu J, Chen FY, Zhou KQ, Zhou C, Cao Y, Sun
HC, Fan J, Zhou J and Wang Z: Intrahepatic cholangiocarcinoma
patients without indications of lymph node metastasis not benefit
from lymph node dissection. Oncotarget. 8:113817–113827. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Aljiffry M, Abdulelah A, Walsh M,
Peltekian K, Alwayn I and Molinari M: Evidence-based approach to
cholangiocarcinoma: A systematic review of the current literature.
J Am Coll Surg. 208:134–147. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Poultsides GA, Zhu AX, Choti MA and Pawlik
TM: Intrahepatic cholangiocarcinoma. Surg Clin North Am.
90:817–837. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lin XH and Luo JC: The risk factors and
prognostic factors of intrahepatic cholangiocarcinoma. J Chin Med
Assoc. 80:121–122. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The Eighth Edition AJCC Cancer Staging Manual:
Continuing to build a bridge from a population-based to a more
‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yamashita YI, Shirabe K, Beppu T, Eguchi
S, Nanashima A, Ohta M, Ueno S, Kondo K, Kitahara K, Shiraishi M,
et al: Surgical management of recurrent intrahepatic
cholangiocarcinoma: predictors, adjuvant chemotherapy, and surgical
therapy for recurrence: A multi-institutional study by the Kyushu
Study Group of Liver Surgery. Ann Gastroenterol Surg. 1:136–142.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Spolverato G, Ejaz A, Kim Y, Sotiropoulos
GC, Pau A, Alexandrescu S, Marques H, Pulitano C, Barroso E, Clary
BM, et al: Tumor size predicts vascular invasion and histologic
grade among patients undergoing resection of intrahepatic
cholangiocarcinoma. J Gastrointest Surg. 18:1284–1291. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fritz A, Percy C, Jack A, Shanmugaratnam
K, Sobin L and Parkin DM: International classification of diseases
for oncology (ICD-O)3ed. Geneva: World Health Organization;
2013
|
|
10
|
Lee AJ and Chun YS: Intrahepatic
cholangiocarcinoma: The AJCC/UICC 8th edition updates. Chin Clin
Oncol. 7:522018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Camp RL, Dolled-Filhart M and Rimm DL:
X-tile: A new bio-informatics tool for biomarker assessment and
outcome-based cut-point optimization. Clin Cancer Res.
10:7252–7259. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim Y, Moris DP, Zhang XF, Bagante F,
Spolverato G, Schmidt C, Dilhoff M and Pawlik TM: Evaluation of the
8th edition American Joint Commission on Cancer (AJCC) staging
system for patients with intrahepatic cholangiocarcinoma: A
surveillance, epidemiology, and end results (SEER) analysis. J Surg
Oncol. 116:643–650. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y, Li J, Xia Y, Gong R, Wang K, Yan
Z, Wan X, Liu G, Wu D, Shi L, et al: Prognostic nomogram for
intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin
Oncol. 31:1188–1195. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Clark CJ, Wood-Wentz CM, Reid-Lombardo KM,
Kendrick ML, Huebner M and Que FG: Lymphadenectomy in the staging
and treatment of intrahepatic cholangiocarcinoma: A
population-based study using the National Cancer Institute SEER
database. HPB (Oxford). 13:612–620. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bunsiripaiboon P, Sornmayura P,
Wilasrusmee C and Lertsithichai P: The prognostic significance of
microvessel density in intrahepatic cholangiocarcinoma. J Med Assoc
Thai. 93:66–72. 2010.PubMed/NCBI
|
|
16
|
Tamandl D, Herberger B, Gruenberger B,
Puhalla H, Klinger M and Gruenberger T: Influence of hepatic
resection margin on recurrence and survival in intrahepatic
cholangiocarcinoma. Ann Surg Oncol. 15:2787–2794. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ribero D, Pinna AD, Guglielmi A, Ponti A,
Nuzzo G, Giulini SM, Aldrighetti L, Calise F, Gerunda GE, Tomatis
M, et al: Surgical approach for long-term survival of patients with
intrahepatic cholangiocarcinoma: A multi-institutional analysis of
434 patients. Arch Surg. 147:1107–1113. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fisher SB, Patel SH, Kooby DA, Weber S,
Bloomston M, Cho C, Hatzaras I, Schmidt C, Winslow E, Staley CA
III, et al: Lymphovascular and perineural invasion as selection
criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: A
multi-institution analysis. HPB (Oxford). 14:514–522. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hyder O, Marques H, Pulitano C, Marsh JW,
Alexandrescu S, Bauer TW, Gamblin TC, Sotiropoulos GC, Paul A,
Barroso E, et al: A nomogram to predict long-term survival after
resection for intrahepatic cholangiocarcinoma: An Eastern and
Western experience. JAMA Surg. 149:432–438. 2014. View Article : Google Scholar : PubMed/NCBI
|
